ZeroStack Corp. (ZSTK) Stock Analysis

What ZeroStack Corp. does

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Key metrics

ETFs linked to ZSTK

Broad-market and Financial Services sector ETFs an investor holding ZeroStack Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ZSTK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for ZeroStack Corp.?

ZeroStack Corp. trades under the ticker ZSTK on NASDAQ.

Which exchange is ZSTK listed on?

ZSTK is listed on NASDAQ.

What sector does ZeroStack Corp. operate in?

ZeroStack Corp. is classified in the Financial Services sector (Asset Management industry).

How can PortView help analyze ZSTK in a portfolio?

PortView shows ZSTK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.